NSE filing, NSE: SAREGAMA. Summary written from the filing by ALFA Finder's alert engine.
Saregama India Ltd: key numbers
- Share price
- ₹523.95
- Market cap
- ₹10,102 Cr
- Revenue (annual)
- ₹984.6 Cr
- Net profit (annual)
- ₹207.1 Cr
- P/E (TTM)
- 45.8×Sector 27.9×
- Promoter holding
- 60.84%+0.00% QoQ
- FII holding
- 11.88%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Saregama India Ltd
All →Saregama India Other Announcement
Saregama India Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026. This disclosure reports the current stake distribution among its shareholders.
Saregama India Annual General Meeting
Saregama India held its 79th AGM on September 15, 2026, via video conferencing. The meeting covered routine business, including the adoption of financial statements and audit resolutions.
Saregama India Annual General Meeting
Saregama India Limited has issued the notice for its 79th Annual General Meeting scheduled for September 15, 2026. The agenda includes financial statement adoption and director re-appointment.
Saregama India Other Announcement
Saregama India Limited shared the web-link for its FY 2025-26 Integrated Annual Report. The company's 79th Annual General Meeting is scheduled for September 15, 2026.
Saregama India Annual Report
Saregama India Limited has released its Integrated Annual Report for FY 2025-26. The 79th Annual General Meeting is scheduled for September 15, 2026, via video conferencing.
Saregama India Management Change
Saregama announced leadership changes at its subsidiary, Pocket Aces. Vinay Pillai is elevated to CEO, while Aditi Shrivastava transitions to a strategic board role.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date